-
CJ’s successive global strategy
2022.09.20 -
Samsung Biologics, C&T’s Life Science Fund invests in Senda Biosciences
2022.09.15 -
Celltrion succeeds 110 billion won supply deal with Teva
2022.09.15 -
On-site Interview - Who's who in BIX
2022.09.15 -
Conference for Bio Insight, BIX2022
2022.09.15 -
Summer in BIX, Grand Opening
2022.09.15 -
Exhibition for Bio Value Chain, BIX2022
2022.08.24 -
The global leader in exosome-based therapeutics, ILIAS Biologics, Inc.
2022.08.24 -
[BIX2022] BIX 2022 Conference Sessions – DAY 3
2022.08.10 -
[BIX2022] BIX 2022 Conference Sessions – DAY 2
2022.08.10 -
[BIX2022] BIX 2022 Conference Sessions – DAY 1
2022.08.10 -
[BIX2022] Keynote sessions at BIX 2022
2022.08.10 -
[BIX2022] Global Bio Gurus all gather in Seoul
2022.07.27 -
Round up News of the Month!
2022.07.27 -
[BIOUSA] K-bio looks for global partnering opportunities
2022.07.27 -
[BIOUSA] KoreaBIO and US BIO strengthen cooperation
2022.07.27 -
[BIOUSA] K-bio as a magnet for investments
2022.07.27 -
[BIOUSA] K-bio, the star at BIO USA
2022.07.12 -
[BIOUSA] Samsung Biologics booth gains a great popularity
2022.07.12 -
[BIOUSA] K-bio proves global competitiveness
2022.07.12